Human data remain insufficient, and clinical trials are merely commencing to investigate the impact of varying doses on individuals
Peptides are not illegal to use or own, but as the BBC notes, "they are not approved for human use, so are not subject to the quality controls that govern pharmaceutical manufacturing." In 2023, under the Biden administration, the FDA classified a group of over a dozen peptides as Category 2 substances, which may "present significant safety risks," effectively banning their use
When sun damage is significant, we almost always recommend a biostimulatory filler be used with laser or ultrasound treatment, as this provides the greatest improvement in skin quality
Timelines vary by treatment and individual
Studies documented growth factor upregulation and cellular migration patterns to injury sites
Neuronal effects of acute citalopram detected by pharmacoMRI